Krispy Kreme vs. McDonald's: Which Restaurant Stock Is a Better Buy in 2026?

Krispy Kreme’s FY 2025 results were weak, with revenue down 8.6% to $1.5B, a net loss of $515.8M, and negative free cash flow of -$64M, alongside heavy leverage (debt-to-equity 2.2x) and a very low current ratio (0.4x). McDonald’s, by contrast, posted FY 2025 revenue of $26.9B (+3.7%), net income of $8.6B, and strong free cash flow of $7.2B with a robust net margin of 31.9%, despite litigation and labor/regulatory scrutiny. Overall, the article argues McDonald’s is the better 2026 buy, while highlighting Krispy Kreme’s turnaround and financial risk profile.

Analysis

The market mechanism here is not “cheap vs expensive,” it is balance-sheet durability versus equity optionality. DNUT’s operating model still behaves like a levered distribution business: if same-store demand weakens, the combination of high fixed logistics costs, supplier concentration, and weak liquidity can turn modest revenue slippage into an equity wipeout faster than consensus models assume. The important second-order effect is that any further channel contraction would likely pressure trade credit terms and vendor economics before it shows up in the headline P&L.

MCD is less a growth story than a capital allocation compounder with an embedded short-vol profile. In a slower consumer tape, its scale and franchise structure should continue to attract share from smaller QSR brands and from premium beverage/snack names that depend on higher-ticket traffic; the bigger risk is not near-term demand but multiple compression if investors stop paying for perceived defensiveness. The hidden upside for MCD is that even flat comps can still translate into outsized per-share growth through buybacks, while DNUT has to first earn the right to refinance.

Consensus is already correctly bearish on DNUT’s equity story, but may still underestimate how asymmetric the downside is if the market tests refinancing windows over the next 6-12 months. For MCD, the move is probably only partially priced: it is a slow, durable relative winner, not a high-beta re-rating candidate. The thesis would be falsified if DNUT posts consecutive quarters of positive free cash flow and leverage reduction, or if MCD’s U.S. same-store sales and traffic roll over enough to threaten the buyback/dividend machine.

Key Decisions for Investors

• Long MCD / short DNUT as a 3-6 month relative-value pair; thesis is quality spread widening as credit and liquidity concerns punish the lower-balance-sheet-quality name first.
• If borrow is available, short DNUT into any post-earnings strength; risk/reward remains favorable until management proves FCF breakeven and materially lower leverage, not just cost cuts.
• Use MCD as a defensive consumer staple proxy versus QSR/SBUX if macro data soften over the next 1-3 months; MCD should retain relative traffic and pricing power better than peers exposed to higher ticket sizes.
• Watch DNUT credit spreads and refinancing commentary over the next 6-12 months; a widening spread or covenant concern would be the cleanest confirmation to add to the short.
• For MCD longs, prefer stock over upside calls unless valuation resets; the core return driver is steady buybacks/dividend compounding, not near-term multiple expansion.